| 1 |
任成山,王关嵩,钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/OL]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
|
| 2 |
Chow R, So OW, Im JHB, et al. Predictors of readmission, for patients with chronic obstructive pulmonary disease (COPD)-A systematic review[J]. Int J Chron Obstruct Pulmon Dis, 2023, 18: 2581-2617.
|
| 3 |
Siu DCH, Gafni-Lachter L. Addressing barriers to chronic obstructive pulmonary disease (COPD) care: Three innovative evidence-based approaches: A review[J]. Int J Chron Obstruct Pulmon Dis, 2024, 19: 331-341.
|
| 4 |
Kahnert K, Jörres RA, Behr J, et al. The diagnosis and treatment of COPD and its comorbidities[J]. Dtsch Arztebl Int, 2023, 120(25): 434-444.
|
| 5 |
Jeyachandran V, Hurst JR. Advances in chronic obstructive pulmonary disease: management of exacerbations[J]. Br J Hosp Med (Lond), 2022, 83(7): 1-7.
|
| 6 |
Hurst JR, Han MK, Singh B, et al. Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review[J]. Respir Res, 2022, 23(1): 213.
|
| 7 |
Xu J, Zeng Q, Li S, et al. Inflammation mechanism and research progress of COPD[J]. Front Immunol, 2024, 15: 1404615.
|
| 8 |
Lin P, Shen C, Li Q, et al. A systematic review and meta-analysis of chronic obstructive pulmonary disease in asia: risk factors for readmission and readmission rate[J]. BMC Pulm Med, 2024, 24(1): 388.
|
| 9 |
Ji M, Li Y, Zhu X, et al. Associating serum IgM, IgA levels with thoracic CT indicators and pulmonary function indexes in acutely exacerbated chronic obstructive pulmonary disease patients[J]. Discov Med, 2023, 35(178): 815-822.
|
| 10 |
Kyriakopoulos C, Gogali A, Kostikas K, et al. Hypercoagulable state in COPD-A comprehensive literature review[J]. Diagnostics (Basel), 2021, 11(8): 1447.
|
| 11 |
Xiao B, Yang Z, Liang H, et al. Predictive value of D-dimer to albumin ratio for severe illness and mortality in patients with COVID-19[J]. Front Med (Lausanne), 2024, 11: 1410179.
|
| 12 |
Lu W, Jia F, Rao M, et al. Predicting preoperative deep vein thrombosis using d-dimer-to-albumin ratio combined with neutrophil-to-lymphocyte ratio in older patients with hip fracture[J]. Clin Interv Aging, 2025, 20: 873-879.
|
| 13 |
Wei L, Xie H, Wang Q, et al. The prognostic value of preoperative D-dimer to albumin ratio for overall survival and progression-free survival in colorectal cancer[J]. Front Physiol, 2024, 15: 1369855.
|
| 14 |
Thawanaphong S, Nair P. Contemporary concise review 2024: Chronic obstructive pulmonary disease[J]. Respirology, 2025, 30(7): 574-586.
|
| 15 |
Agustí A, Celli BR, Criner GJ, et al. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary[J]. Eur Respir J, 2023, 61(4): 2300239.
|
| 16 |
Xu Z, Li F, Xin Y, et al. Prognostic risk prediction model for patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD): a systematic review and meta-analysis[J]. Respir Res, 2024, 25(1): 410.
|
| 17 |
Neder JA, Berton DC, O′Donnell DE. Using the pulmonary function laboratory to assist in disease management: COPD[J]. J Bras Pneumol, 2023, 49(3): e20230171.
|
| 18 |
高鹏宇. 慢性阻塞性肺疾病急性加重期患者TEG参数与凝血四项指标变化的相关性[J]. 河南医学研究,2021, 30(9): 1706-1708.
|
| 19 |
Reid BE, DiGiuseppe S, Akbarian-Tefaghi H. Elevated D-dimer levels in the exacerbation of end-stage chronic obstructive pulmonary disease(COPD) with hypercapnia[J]. Cureus, 2025, 17(2): e79574.
|
| 20 |
王建国,张东友,李昂,等. D-二聚体在高龄老年慢性阻塞性肺疾病急性加重患者中的临床意义[J]. 中国循证心血管医学杂志,2024, 16(10): 1250-1252.
|
| 21 |
武晓敏,李雷花. D-二聚体与纤维蛋白原比值在慢性阻塞性肺疾病急性加重期患者中的表达及临床意义[J]. 河南医学研究,2024, 33(8): 1430-1433.
|
| 22 |
Lan CC, Yang MC, Su WL, et al. Unraveling the immune landscape of chronic obstructive pulmonary disease: Insights into inflammatory cell subtypes, pathogenesis, and treatment strategies[J]. Int J Mol Sci, 2025, 26(7): 3365.
|
| 23 |
Cai C, Zeng W, Wang H, et al. Neutrophil-to-lymphocyte ratio (NLR), Platelet-to-lymphocyte ratio (PLR) and Monocyte-to-lymphocyte ratio (MLR) as biomarkers in diagnosis evaluation of acute exacerbation of chronic obstructive pulmonary disease: A retrospective, observational study[J]. Int J Chron Obstruct Pulmon Dis, 2024, 19: 933-943.
|
| 24 |
王丽萍,王真真,葛庆波,等. A2DS2评分联合中性粒细胞百分比/白蛋白比值、D-二聚体对AIS患者发生卒中相关性肺炎的预测价值[J]. 现代生物医学进展,2025, 25(14): 2335-2342.
|
| 25 |
任思达,吴展陵. 超敏C反应蛋白/前白蛋白、D-二聚体在结核性渗出性胸膜炎中表达水平及诊断价值[J]. 中国医学工程,2024, 32(6): 52-56.
|
| 26 |
Eygi E, Bayrakci S. Association of albumin-to-D-dimer ratio with mortality in mechanically ventilated intensive care patients[J]. J Clin Med, 2025, 14(11): 3917.
|
| 27 |
Kyriakopoulos C, Chronis C, Papapetrou E, et al. Prothrombotic state in patients with stable COPD: an observational study[J]. ERJ Open Res, 2021, 7(4): 00297-2021.
|
| 28 |
Zinellu E, Fois AG, Sotgiu E, et al. Serum albumin concentrations in stable chronic obstructive pulmonary disease: A systematic review and meta-analysis[J]. J Clin Med, 2021, 10(2): 269.
|
| 29 |
Sun J, Liao X, Yan Y, et al. Detection and staging of chronic obstructive pulmonary disease using a computed tomography-based weakly supervised deep learning approach[J]. Eur Radiol, 2022, 32(8): 5319-5329.
|
| 30 |
Zou X, Tian B, Lin Q, et al. Diagnostic value of CT in patients with stable chronic obstructive pulmonary disease at high altitude: Observational study[J]. Medicine (Baltimore), 2024, 103(44): e40291.
|
| 31 |
徐纪文,徐静雅,宗斌,等. COPD并发肺部感染TLR4/NF-κB通路与细胞因子水平及意义[J/OL]. 中华肺部疾病杂志(电子版), 2022, 15(2): 221-223.
|
| 32 |
Liu Q, Wu B, Xie R, et al. Association between serum albumin and pulmonary function in adolescents: analyses of NHANES 2007-2012[J]. BMC Pulm Med, 2024, 24(1): 554.
|
| 33 |
Aydin C, Yıldız BP, Hattatoglu DG. D-dimer/Fibrinogen ratio and recurrent exacerbations might have a potential impact to predict 90-day mortality in patients with COPD exacerbation[J]. Malawi Med J, 2021, 33(4): 276-280.
|